A recent study indicates that individuals who discontinue new slimming jabs like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who halt traditional lifestyle programs.
Findings released in a major health publication demonstrates that while overweight individuals frequently drop about a fifth of their total mass while using the jabs, the mass is regained at an average rate of 0.8 kg per month once they quit.
"Users using these medications should be cognizant of the potential of quick weight regain when the treatment concludes," stated expert Dr. Susan Jebb.
Such speed of recovery implies a return to starting mass within about a year and a half.
Weighing Treatments
The analysis, which reviewed 37 of trials involving thousands of participants, compared the effects of these new drugs with other pills.
Researchers note that individuals who lose weight through dieting typically have a slower creep back—around 100 grams monthly—after stopping.
Explaining the Quick Regain
Nutrition scientists suggest the mechanism of the jabs accounts for the heightened rebound.
GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate appetite.
"Sustained high doses of the hormone concentrations several times higher than normal might result in the system to produce less of its own natural GLP-1, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this GLP-1 'fix' results in hunger is no longer kept in check, making overeating much more probable."
A Lifelong Issue?
Health authorities recommend the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, due to the high risk of weight regain, the therapy might need to be long-term.
This view is reinforced by pharmaceutical companies, who note that the results "highlight the persistent nature of obesity," comparing it to managing conditions like high blood pressure.
Patient Accounts
People who have discontinued the medication explain a sudden return of cravings.
"It was like a switch activating and I was suddenly ravenous," said an individual.
This difficulty is exacerbated if users have not established sustainable dietary or behavioural modifications during treatment.
Growing Interest
Recent estimates suggest that millions of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Use is greater among females compared to males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
In conclusion, researchers emphasize that while the jabs are effective tools for shedding pounds, they are not a magic cure and lasting health benefits likely depends on integrated lifestyle support.
